OTC Pharmaceuticals - Worldwide

Worldwide

Revenue in the OTC Pharmaceuticals market amounts to €181.40bn in 2023. The market is expected to grow annually by 5.40% (CAGR 2023-2028).
The market's largest segment is the segment Cold & Cough Remedies with a market volume of €38.76bn in 2023.
In global comparison, most revenue is generated in the United States (€36,930m in 2023).
In relation to total population figures, per person revenues of €23.60 are generated in 2023.
In the OTC Pharmaceuticals market, 26.4% of total revenue will be generated through online sales by 2023.

Key regions: Worldwide, India, Philippines, United States, Europe

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

Due to different national legislations and healthcare standards, the consumption of OTC pharmaceuticals and purchasing behavior regarding these products differs significantly from country to country. The worldwide improvement in access to healthcare and pharmaceuticals directly affects OTC pharmaceuticals sales. Generally speaking, the better the access to medicine, the more medicine is taken. However, as access to medicine varies considerably from country to country, factors such as the political will to improve the healthcare system can also influence the market and the forecast regarding the market.

Methodology

The OTC Pharmaceuticals market is built on resources from the Statista platform as well as on in-house market research, national statistical offices, international institutions, trade associations, companies, the trade press, and the experience of our analysts. We evaluate the status quo of the market, monitor trends, and create an independent forecast regarding market developments of the global OTC Pharmaceuticals industry.